The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Atropine Sulfate Market Research Report 2024
Synopsis
Atropine Sulfate is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
The global Atropine Sulfate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Atropine Sulfate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine Sulfate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atropine Sulfate include C2PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atropine Sulfate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine Sulfate.
Report Scope
The Atropine Sulfate market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atropine Sulfate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine Sulfate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
C2PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine Sulfate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine Sulfate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Atropine Sulfate is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
The global Atropine Sulfate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Atropine Sulfate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine Sulfate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atropine Sulfate include C2PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atropine Sulfate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine Sulfate.
Report Scope
The Atropine Sulfate market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atropine Sulfate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine Sulfate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
C2PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine Sulfate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine Sulfate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Atropine Sulfate Market Overview
1.1 Product Overview and Scope of Atropine Sulfate
1.2 Atropine Sulfate Segment by Type
1.2.1 Global Atropine Sulfate Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Atropine Sulfate Segment by Application
1.3.1 Global Atropine Sulfate Market Value by Application: (2024-2030)
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Global Atropine Sulfate Market Size Estimates and Forecasts
1.4.1 Global Atropine Sulfate Revenue 2019-2030
1.4.2 Global Atropine Sulfate Sales 2019-2030
1.4.3 Global Atropine Sulfate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atropine Sulfate Market Competition by Manufacturers
2.1 Global Atropine Sulfate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atropine Sulfate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atropine Sulfate Average Price by Manufacturers (2019-2024)
2.4 Global Atropine Sulfate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atropine Sulfate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atropine Sulfate, Product Type & Application
2.7 Atropine Sulfate Market Competitive Situation and Trends
2.7.1 Atropine Sulfate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atropine Sulfate Players Market Share by Revenue
2.7.3 Global Atropine Sulfate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atropine Sulfate Retrospective Market Scenario by Region
3.1 Global Atropine Sulfate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atropine Sulfate Global Atropine Sulfate Sales by Region: 2019-2030
3.2.1 Global Atropine Sulfate Sales by Region: 2019-2024
3.2.2 Global Atropine Sulfate Sales by Region: 2025-2030
3.3 Global Atropine Sulfate Global Atropine Sulfate Revenue by Region: 2019-2030
3.3.1 Global Atropine Sulfate Revenue by Region: 2019-2024
3.3.2 Global Atropine Sulfate Revenue by Region: 2025-2030
3.4 North America Atropine Sulfate Market Facts & Figures by Country
3.4.1 North America Atropine Sulfate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atropine Sulfate Sales by Country (2019-2030)
3.4.3 North America Atropine Sulfate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atropine Sulfate Market Facts & Figures by Country
3.5.1 Europe Atropine Sulfate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atropine Sulfate Sales by Country (2019-2030)
3.5.3 Europe Atropine Sulfate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Sulfate Market Facts & Figures by Country
3.6.1 Asia Pacific Atropine Sulfate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atropine Sulfate Sales by Country (2019-2030)
3.6.3 Asia Pacific Atropine Sulfate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atropine Sulfate Market Facts & Figures by Country
3.7.1 Latin America Atropine Sulfate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atropine Sulfate Sales by Country (2019-2030)
3.7.3 Latin America Atropine Sulfate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atropine Sulfate Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Sulfate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atropine Sulfate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atropine Sulfate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Atropine Sulfate Sales by Type (2019-2030)
4.1.1 Global Atropine Sulfate Sales by Type (2019-2024)
4.1.2 Global Atropine Sulfate Sales by Type (2025-2030)
4.1.3 Global Atropine Sulfate Sales Market Share by Type (2019-2030)
4.2 Global Atropine Sulfate Revenue by Type (2019-2030)
4.2.1 Global Atropine Sulfate Revenue by Type (2019-2024)
4.2.2 Global Atropine Sulfate Revenue by Type (2025-2030)
4.2.3 Global Atropine Sulfate Revenue Market Share by Type (2019-2030)
4.3 Global Atropine Sulfate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atropine Sulfate Sales by Application (2019-2030)
5.1.1 Global Atropine Sulfate Sales by Application (2019-2024)
5.1.2 Global Atropine Sulfate Sales by Application (2025-2030)
5.1.3 Global Atropine Sulfate Sales Market Share by Application (2019-2030)
5.2 Global Atropine Sulfate Revenue by Application (2019-2030)
5.2.1 Global Atropine Sulfate Revenue by Application (2019-2024)
5.2.2 Global Atropine Sulfate Revenue by Application (2025-2030)
5.2.3 Global Atropine Sulfate Revenue Market Share by Application (2019-2030)
5.3 Global Atropine Sulfate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 C2PHARMA
6.1.1 C2PHARMA Corporation Information
6.1.2 C2PHARMA Description and Business Overview
6.1.3 C2PHARMA Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 C2PHARMA Atropine Sulfate Product Portfolio
6.1.5 C2PHARMA Recent Developments/Updates
6.2 RESONANCE LABORATORIES
6.2.1 RESONANCE LABORATORIES Corporation Information
6.2.2 RESONANCE LABORATORIES Description and Business Overview
6.2.3 RESONANCE LABORATORIES Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 RESONANCE LABORATORIES Atropine Sulfate Product Portfolio
6.2.5 RESONANCE LABORATORIES Recent Developments/Updates
6.3 ROLABO OUTSOURCING
6.3.1 ROLABO OUTSOURCING Corporation Information
6.3.2 ROLABO OUTSOURCING Description and Business Overview
6.3.3 ROLABO OUTSOURCING Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ROLABO OUTSOURCING Atropine Sulfate Product Portfolio
6.3.5 ROLABO OUTSOURCING Recent Developments/Updates
6.4 Minsheng
6.4.1 Minsheng Corporation Information
6.4.2 Minsheng Description and Business Overview
6.4.3 Minsheng Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Minsheng Atropine Sulfate Product Portfolio
6.4.5 Minsheng Recent Developments/Updates
6.5 CR Double-Crane
6.5.1 CR Double-Crane Corporation Information
6.5.2 CR Double-Crane Description and Business Overview
6.5.3 CR Double-Crane Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CR Double-Crane Atropine Sulfate Product Portfolio
6.5.5 CR Double-Crane Recent Developments/Updates
6.6 HENAN PURUI
6.6.1 HENAN PURUI Corporation Information
6.6.2 HENAN PURUI Description and Business Overview
6.6.3 HENAN PURUI Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HENAN PURUI Atropine Sulfate Product Portfolio
6.6.5 HENAN PURUI Recent Developments/Updates
6.7 Albany Molecular Research
6.6.1 Albany Molecular Research Corporation Information
6.6.2 Albany Molecular Research Description and Business Overview
6.6.3 Albany Molecular Research Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Albany Molecular Research Atropine Sulfate Product Portfolio
6.7.5 Albany Molecular Research Recent Developments/Updates
6.8 Alchem International
6.8.1 Alchem International Corporation Information
6.8.2 Alchem International Description and Business Overview
6.8.3 Alchem International Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Alchem International Atropine Sulfate Product Portfolio
6.8.5 Alchem International Recent Developments/Updates
6.9 SAURAV CHEMICALS
6.9.1 SAURAV CHEMICALS Corporation Information
6.9.2 SAURAV CHEMICALS Description and Business Overview
6.9.3 SAURAV CHEMICALS Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SAURAV CHEMICALS Atropine Sulfate Product Portfolio
6.9.5 SAURAV CHEMICALS Recent Developments/Updates
6.10 Katsura Chemical
6.10.1 Katsura Chemical Corporation Information
6.10.2 Katsura Chemical Description and Business Overview
6.10.3 Katsura Chemical Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Katsura Chemical Atropine Sulfate Product Portfolio
6.10.5 Katsura Chemical Recent Developments/Updates
6.11 Hangzhou Vega
6.11.1 Hangzhou Vega Corporation Information
6.11.2 Hangzhou Vega Atropine Sulfate Description and Business Overview
6.11.3 Hangzhou Vega Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hangzhou Vega Atropine Sulfate Product Portfolio
6.11.5 Hangzhou Vega Recent Developments/Updates
6.12 Wuhan senwayer century
6.12.1 Wuhan senwayer century Corporation Information
6.12.2 Wuhan senwayer century Atropine Sulfate Description and Business Overview
6.12.3 Wuhan senwayer century Atropine Sulfate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wuhan senwayer century Atropine Sulfate Product Portfolio
6.12.5 Wuhan senwayer century Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Sulfate Industry Chain Analysis
7.2 Atropine Sulfate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Sulfate Production Mode & Process
7.4 Atropine Sulfate Sales and Marketing
7.4.1 Atropine Sulfate Sales Channels
7.4.2 Atropine Sulfate Distributors
7.5 Atropine Sulfate Customers
8 Atropine Sulfate Market Dynamics
8.1 Atropine Sulfate Industry Trends
8.2 Atropine Sulfate Market Drivers
8.3 Atropine Sulfate Market Challenges
8.4 Atropine Sulfate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
